Clinical Trial Update: A Phase 2 Study of Atacicept in Subjects With Relapsing Multiple Sclerosis (ATAMS) [Phase 2]

View source ↗

Summary

This update reports results from a Phase 2 study of atacicept in relapsing multiple sclerosis (ATAMS). The trial was terminated and results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing Multiple Sclerosis

Drugs mentioned

• Atacicept (atacicept)

Snippet

Sponsor: EMD Serono | Conditions: Relapsing Multiple Sclerosis | Phase 2 | Status: TERMINATED | Results posted: 2016-05-24